← 產業報告目錄

CBD API Market Size, Share & Trends Analysis Report By Product (Full Spectrum CBD, Broad Spectrum CBD, CBD Isolate, Water Dispersible CBD Powder), By Origin( Natural, Synthetic), By Indication, By End-User, By Route of Administration, By Region, And by Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-07頁數 180報告編號 INSIGHTACE-84709fc001

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

The global CBD API Market is expected to witness pronounced expansion over the coming years. CBD API covers key industry insights & findings from the report: Cbd has been recommended for a range of health conditions, it is considered the best treatment while considering the worst childhood epilepsy disorde. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Cannabidiol (CBD) API Market Snapshot Chapter 4. Global Cannabidiol (CBD) API Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Origin, Estimates & Trend Analysis 5.1. By Origin, & Market Share, 2024 & 2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Origin: 5.2.1. Natural 5.2.2. Synthetic Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis 6.1. By Products & Market Share, 2024 & 2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products: 6.2.1. Full spectrum CBD 6.2.2. Broad-spectrum CBD 6.2.3. CBD isolate 6.2.4. Water Dispersible CBD Powder 6.2.5. Other Products Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis 7.1. By Indication & Market Share, 2024 & 2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication: 7.2.1. Alzheimer's Disease 7.2.2. Autism 7.2.3. Cancer 7.2.4. Chronic Pain 7.2.5. Epilepsy 7.2.6. Migraine 7.2.7. Multiple Sclerosis 7.2.8. Schizophrenia 7.2.9. Other Indications Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis 8.1. By End-Users & Market Share, 2024 & 2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users: 8.2.1. Pharmaceutical Industry 8.2.2. Academic & Clinical Research Institutes Chapter 9. Cannabidiol (CBD) API Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Origin, 2021-2034 9.1.2. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034 9.1.3. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034 9.1.4. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034 9.1.5. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, 2021-2034 9.2.2. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Products, 2021-2034 9.2.3. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, 2021-2034 9.2.4. Europe Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034 9.2.5. Europe Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, 2021-2034 9.3.2. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Products, 2021-2034 9.3.3. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, 2021-2034 9.3.4. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034 9.3.5. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2021-2034 9.4. Latin America 9.4.1. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, (US$ Million) 2021-2034 9.4.2. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Products, (US$ Million) 2021-2034 9.4.3. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034 9.4.4. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034 9.4.5. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, (US$ Million) 2021-2034 9.5.2. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Products, (US$ Million) 2021-2034 9.5.3. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034 9.5.4. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034 9.5.5. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. Recipharm 10.2.1.1. Business Overview 10.2.1.2. Key Product/Service Overview 10.2.1.3. Financial Performance 10.2.1.4. Geographical Presence 10.2.1.5. Recent Developments with Business Strategy 10.2.2. brains bioceutical 10.2.3. Purisys 10.2.4. DSM 10.2.5. Bedrocan 10.2.6. Vantage Hemp 10.2.7. Eurofins 10.2.8. BIOVECTRA Inc. 10.2.9. EndoPure 10.2.10. Biosyyd, UAB 10.2.11. KD Pharma Group 10.2.12. Folium Biosciences 10.2.13. Kinetochem 10.2.14. Colombian Golden 10.2.15. Averix Bio, LLC 10.2.16. Veranova 10.2.17. KND Labs 10.2.18. Jordan Process 10.2.19. GVB Biopharma 10.2.20. Other Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們